Dosage and administration
shake well before using apply as needed
shake well before using apply as needed
store at 59⁰ - 86⁰ F
Calamine 8%
Zinc oxide 8%
Skin Protectant
dries the oozing and weeping of poison:
For external use only
Do not get into eyes
If swallowed, get medical help or contact a Poison Control Center right away.
store at 59⁰ - 86⁰ F
bentonite magma, calcium hydroxide, glycerin, purified water
1-888-423-0139
DISTRIBUTED BY TOPCO ASSOCIATES LLC
ELK GROVE VILLAGE, IL 60007
©TOPCO VIJA0622 QUESTIONS? 1-888-423-0139
topcare@topco.com
www.topcarebrand.com
Visit here for more information:
QUALITY GUARANTEED
NDC 36800-063-30
TopCare ®health
Calamine Lotion USP
CALAMINE TOPICAL SUSPENSION USP
SKIN PROTECTANT
Drying Lotion for:
6 FL OZ (177 mL)
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 36800-063-26 | Calamine | 237 mL in 1 BOTTLE, PLASTIC | LOTION | 237 | 22 | |
| 36800-063-30 | Calamine | 177 mL in 1 BOTTLE, PLASTIC | LOTION | 177 | 22 | |
| 36800-063-34 | Calamine | 237 mL in 1 BOTTLE, PLASTIC | LOTION | 237 | 22 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 36800-063-30 | ML - Milliliter | 36800-063 | ba0277e0-25f2-46b1-b6ce-22e95cb90c97 | 1 | 2020-08-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| FERRIC OXIDE RED | ACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| FERRIC OXIDE RED | ACTIVE MOIETY | 1K09F3G675 | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| BENTONITE | INACTIVE INGREDIENT | A3N5ZCN45C | 1 | |
| CALCIUM HYDROXIDE | INACTIVE INGREDIENT | PF5DZW74VN | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 36800-063 | 36800-063-30, 36800-063-26, 36800-063-34 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENTONITE | A3N5ZCN45C | IACT |
| CALCIUM HYDROXIDE | PF5DZW74VN | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| FERRIC OXIDE RED | 1K09F3G675 | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| CALCIUM HYDROXIDE | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine | FERRIC OXIDE RED | Topco Associates LLC | 2b32e720-ac71-4d60-bc06-e28a00f8a450 | 2026-02-13 | Warnings, Adverse reactions | 36800-063-34 36800-063-30 36800-063-26 36800-063 36800006334 36800006330 36800006326 4ab7ad96-87b5-6284-e063-6294a90ae847 2b32e720-ac71-4d60-bc06-e28a00f8a450 |
Adverse event summaries are temporarily unavailable. Other product information remains available.